CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Oncodesign Precision Medicine

ALOPM.PA
$5MMicro Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for ALOPM.PA. That does not mean none is planned.

Get an email about ALOPM.PA's next catalysts

Track Oncodesign Precision Medicine (ALOPM.PA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

Market Overview

Stock performance and key metrics

Euronext ParisBiotechnology🇫🇷Europe13 employees
Drug Pipeline

No drugs found in this phase.

Frequently asked questions

When is Oncodesign Precision Medicine's next FDA catalyst?→

CatalystAlert tracks every upcoming catalyst for Oncodesign Precision Medicine (ALOPM.PA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.

How do I track ALOPM.PA biotech catalysts?→

Add ALOPM.PA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Oncodesign Precision Medicine's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply